{"database": "lobbying", "table": "lobbying_activities", "rows": [[1658429, "16c26262-9427-452e-9872-12b8462f45d9", "1A", "DALRYMPLE & ASSOCIATES, LLC", 5073, "EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION)", 2015, "first_quarter", "HOM", "Advocating the availability of FDA approved medical countermeasures for the protection of emergency responders against CBRN threats on a voluntary basis under appropriate medical supervision", "Centers For Disease Control & Prevention (CDC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Defense Logistics Agency,Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Natl Institutes of Health (NIH),SENATE,White House Office", 46000, null, 0, 0, "2015-04-10T12:57:57.780000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1658429"], "units": {}, "query_ms": 14.817859992035665, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}